The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance
November 09, 2022 16:05 ET
|
Toi Management, LLC
CERRITOS, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today reported...
The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference
November 01, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief...
The Oncology Institute Announces Third Quarter 2022 Earnings Release Date and Conference Call
October 19, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the...
The Oncology Institute Executives to Speak at Key Industry Conferences in Q4
October 17, 2022 16:05 ET
|
Toi Management, LLC
CERRITOS, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, announced its executives'...
The Oncology Institute Announces New Leaders to Oversee Technology and Clinical Trials
October 11, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, is pleased to announce the hiring...
The Oncology Institute Expands into South Florida
October 06, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Oct. 06, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced its entrance...
The Oncology Institute Enrolls Nation’s First Two Patients in a Phase 3 Open-Label, Randomized Clinical Trial of Pirtobrutinib
September 29, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), today announces the enrollment of two of its patients as the first and second patients dosed in the...
The Oncology Institute Appoints Two New Board Members
September 22, 2022 16:05 ET
|
Toi Management, LLC
CERRITOS, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, today announced the...
The Oncology Institute to Participate at the Nephron 2nd Annual Physician Enablement Symposium
September 15, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief...
The Oncology Institute Becomes Certified as a Patient Safety Organization
September 12, 2022 08:00 ET
|
Toi Management, LLC
CERRITOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based community oncology groups in the United States, announced today an...